Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 31,131 | $0.00 Strike: $41.64 | $0.00 |
DisclosureSEC source: 0001104659-07-006232 · a4.xml · derivative · entry 10 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 31,131 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 80,634 | $52.55 | $4,237,316.70 |
DisclosureSEC source: 0001104659-07-006232 · a4.xml · nonDerivative · entry 5 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,894 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 39,015 | $41.03 | $1,600,851.78 |
DisclosureSEC source: 0001104659-07-006232 · a4.xml · nonDerivative · entry 4 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 24,684 | $41.07 | $1,013,754.60 |
DisclosureSEC source: 0001104659-07-006232 · a4.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 31,131 | $41.64 | $1,296,375.78 |
DisclosureSEC source: 0001104659-07-006232 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
FREYMAN THOMAS CExecutive Vice President
|
SaleCommon shares without par value | 1,845 | $52.57 | $96,991.65 |
DisclosureSEC source: 0001104659-07-006232 · a4.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,698 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 14,991 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · derivative · entry 15 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,991 Underlying: common shares · 14,991 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 18,744 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · derivative · entry 14 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,744 Underlying: common shares · 18,744 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 12,677 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · derivative · entry 13 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,677 Underlying: common shares · 12,677 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 17,734 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · derivative · entry 12 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,866 Underlying: common shares · 17,734 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 22,107 | $0.00 Strike: $41.22 | $0.00 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · derivative · entry 11 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 22,107 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 14,763 | $0.00 Strike: $41.64 | $0.00 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · derivative · entry 10 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 14,763 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,612 | $0.00 Strike: $41.38 | $0.00 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · derivative · entry 9 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,612 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 6,778 | $0.00 Strike: $49.63 | $0.00 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · derivative · entry 8 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 6,778 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon shares without par value | 55,144 | $52.55 | $2,897,817.20 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · nonDerivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,240 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 17,734 | $41.03 | $727,656.17 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · nonDerivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 22,107 | $41.22 | $911,243.91 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · nonDerivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 14,763 | $41.64 | $614,769.70 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 2,612 | $41.38 | $108,084.56 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 6,778 | $49.63 | $336,398.24 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:35 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 22,916 | $0.00 Strike: $48.67 | $0.00 |
DisclosureSEC source: 0001104659-07-006236 · a4.xml · derivative · entry 8 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 22,916 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:35 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,278 | $0.00 Strike: $43.86 | $0.00 |
DisclosureSEC source: 0001104659-07-006236 · a4.xml · derivative · entry 7 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,278 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:35 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,570 | $0.00 Strike: $50.38 | $0.00 |
DisclosureSEC source: 0001104659-07-006236 · a4.xml · derivative · entry 6 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 5,570 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:35 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
SaleCommon shares without par value | 30,764 | $52.67 | $1,620,290.66 |
DisclosureSEC source: 0001104659-07-006236 · a4.xml · nonDerivative · entry 4 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,798 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:35 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionCommon shares without par value | 22,916 | $48.67 | $1,115,321.72 |
DisclosureSEC source: 0001104659-07-006236 · a4.xml · nonDerivative · entry 3 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:35 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,278 | $43.86 | $99,913.08 |
DisclosureSEC source: 0001104659-07-006236 · a4.xml · nonDerivative · entry 2 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:35 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionCommon shares without par value | 5,570 | $50.38 | $280,631.64 |
DisclosureSEC source: 0001104659-07-006236 · a4.xml · nonDerivative · entry 1 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 38,007 | $0.00 Strike: $47.88 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 32 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 38,007 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 23,664 | $0.00 Strike: $49.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 31 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 23,664 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 2,121 | $0.00 Strike: $47.10 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 30 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,121 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 44,046 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 29 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,046 Underlying: common shares · 44,046 shares Expires 2008-09-14 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 132,148 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 28 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,148 Underlying: common shares · 132,148 shares Expires 2008-02-12 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 262,464 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 27 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,464 Underlying: common shares · 262,464 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 51,105 | $0.00 Strike: $40.56 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 26 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,503 Underlying: common shares · 51,105 shares Expires 2008-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 166,189 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 25 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,875 Underlying: common shares · 166,189 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (rightto buy) · Derivative | 339,443 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 24 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: common shares · 339,443 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 36,046 | $52.44 | $1,890,360.38 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 921,973 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 38,007 | $47.88 | $1,819,885.38 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 958,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 22,443 | $52.44 | $1,176,978.25 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920,012 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 23,664 | $49.55 | $1,172,463.64 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 942,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 2,011 | $52.44 | $105,462.87 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918,791 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 2,121 | $47.10 | $99,899.10 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Tax withholdingCommon shares without par value | 438,658 | $52.55 | $23,051,477.90 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918,681 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 51,105 | $40.56 | $2,072,910.79 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,357,339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 166,189 | $34.77 | $5,778,840.24 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,306,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 339,443 | $33.23 | $11,280,166.11 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,140,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,902 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 14 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,902 Underlying: Common shares · 1,902 shares Expires 2008-02-12 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 13 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,275 Underlying: Common shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 85 | $0.00 Strike: $31.43 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 12 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 85 shares Expires 2007-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 4,907 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 11 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 4,907 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.